R&D/Clinical Trials

>

Latest News

HEOR: From Proving Product Value to Proving Its Own Worth
HEOR: From Proving Product Value to Proving Its Own Worth

March 6th 2025

The recent shift in Health Economics and Outcomes Research functions across major pharmaceutical companies highlights a lack of understanding of its value.

AbbVie, Gubra Strike Deal to Develop Novel Weight Loss Treatment
AbbVie, Gubra Strike Deal to Develop Novel Weight Loss Treatment

March 3rd 2025

FDA Approves Investigational New Drug Application for Fapon Biopharma’s Novel Immunotherapy for Solid Tumors
FDA Approves Investigational New Drug Application for Fapon Biopharma’s Novel Immunotherapy for Solid Tumors

February 28th 2025

Lauren D'Angelo
Enhanced Intellectual Property Protection: Q&A with Lauren D’Angelo

February 28th 2025

Ecopipam Demonstrates Promise in Patients with Tourette Syndrome
Ecopipam Demonstrates Promise in Patients with Tourette Syndrome

February 28th 2025

More News

Gene Logic: Rescue Squad

Gene Logic: Rescue Squad

Ron Feemster
February 1st 2006

Pharma has an enormous backlog of drugs that never made it out of clinical trials. At Gene Logic, these discontinued drugs spell opportunity. Not only are they the foundation of a new business unit at Gene Logic, such failed compounds may become the cornerstone of a new approach to R&D as the industry confronts its latest productivity crisis.

Global Report: Moving Towards Generic Biologics

Global Report: Moving Towards Generic Biologics

Sarah Houlton
February 1st 2006

In Europe, seven of the top-10 injectible drugs are biologics. Generic versions could be priced 25 to 40 percent lower than prescriptions.

<1
...
2223242526